Research & Development



  雲瑯雖然心中很不滿,卻沒有表露出來,依舊恭恭敬敬的將人請進家門,準備了好飯好菜招待,雲瑯這個家主也降尊紆貴的全程陪同。   “慶州朱受,他家的閨女不能娶,據說身高丈二,脾性爆烈,有生撕虎豹之能,多年以來隨軍征戰,以女身受軍爵十二,也就比你的少上造低一點。”亚洲   你要是不承認,才讓人看不起!欧洲无码   這是標準的弄錯了計算單位之後獲得的錯誤的答案,兩顆恆星之間相距七萬六千光年有可能,絕對不可能是七萬六千里。   然後兩人相視一笑,很是相得。在线   曹襄走過來想要弄一塊香腸吃,這東西他過年的時候吃過,只是吃過一次,雲瑯就說太少,再也沒讓廚娘給他做過。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo